Neonc Technologies Holdings (NTHI) Change in Cash (2024 - 2026)
Neonc Technologies Holdings (NTHI) posted quarterly Change in Cash of $79872.0 for Q1 2026, down 98.51% year-over-year from $5.4 million in Q1 2025, and up 105.49% quarter-over-quarter from -$1.5 million in Q4 2025.
Neonc Technologies Holdings (NTHI) Change in Cash (2024 - 2026) Analysis & Trends
Neonc Technologies Holdings (NTHI) has reported Change in Cash for 3 consecutive years, with $79872.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Cash fell 98.51% year-over-year to $79872.0; the TTM figure through Mar 2026 stood at -$5.3 million (down 197.54% YoY), while the FY2025 annual figure was -$6164.0, down 118.66% from the prior year.
- Change in Cash climbed to $79872.0 in Q1 2026 per NTHI's latest filing, from -$1.5 million in the prior quarter.
- Across five years, Change in Cash topped out at $5.4 million in Q1 2025 and bottomed at -$5.3 million in Q2 2025.
- Historically, Change in Cash has averaged $11859.9 across 3 years, with a median of -$26848.0 in 2024.
- On a YoY basis, Change in Cash climbed as much as 20117.57% in 2025 and fell as far as 447.9% in 2025.
- Neonc Technologies Holdings' Change in Cash stood at -$1.3 million in 2024, then fell by 14.55% to -$1.5 million in 2025, then surged by 105.49% to $79872.0 in 2026.
- Business Quant data shows NTHI's Change in Cash at $79872.0 in Q1 2026, -$1.5 million in Q4 2025, and $1.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Neonc Technologies Holdings | 116.41 Mn | 116.41 Mn | - | 1.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.83 Mn |
| Mar 31, 2026 | 79,872.00 |
| Dec 31, 2025 | -1.45 Mn |
| Sep 30, 2025 | 1.39 Mn |
| Jun 30, 2025 | -5.31 Mn |
| Mar 31, 2025 | 5.37 Mn |
| Dec 31, 2024 | -1.27 Mn |
| Sep 30, 2024 | -197,907.00 |
| Jun 30, 2024 | 1.53 Mn |
| Mar 31, 2024 | -26,848.00 |